Is elective cancer surgery feasible during the lock‐down period of the COVID‐19 pandemic? Analysis of a single institutional experience of 404 consecutive patients

Autor: Murat Korkmaz, Ece Dilege, Selin Ünsaler, Suat Erus, Sukru Dilege, Onder Ergonul, Dursun Bugra, Dogan Vatansever, Burak Giray, Mert Erkan, Ezgi Cesur, Goktug Akyoldas, Ozan Muzaffer Altuntaş, Ihsan Solaroglu, Emre Balik, Ömer Yavuz, Cemil Burak Kulle, Nahit Cakar, Kayhan Tarim, Orhan Bilge, Murat Can Kiremit, Mehdi Sasani, Erdem Canda, Yakup Kordan, Orhan Agcaoglu, Mert Kilic, Talat Kiris, Ibrahim Fethi Azamat, Ozan Gökler, Mehmet Ali Deveci, Serhan Tanju, Ayşenur Meriç Hafiz, Cagatay Taskiran, Aykın Şimşek
Přispěvatelé: Kulle, Cemil Burak, Azamat, İbrahim Fethi, Ağcaoğlu, Orhan (ORCID 0000-0003-1617-3953 & YÖK ID175476), Dilege, Ece (ORCID 0000-0003-0160-0350 & YÖK ID 218050), Erkan, Murat Mert (ORCID 0000-0002-2753-0234 & YÖK ID 214689), Balık, Emre (ORCID 0000-0001-5751-1133 & YÖK ID 18758), Bilge, Orhan (ORCID 0000-0002-8277-8697 & YÖK ID 176833), Buğra, Dursun (ORCID 0000-0003-0316-6818 & YÖK ID 1758), Vatansever, Doğan (ORCID 0000-0002-7831-7070 & YÖK ID 193687), Taşkıran, Çağatay (ORCID 0000-0002-0936-552X & YÖK ID 134190), Erus, Suat (ORCID 0000-0002-6162-3266 & YÖK ID 175565), Yavuz, Ömer, Tanju, Serhan (ORCID 0000-0002-2363-233X & YÖK ID 214690), Dilege, Mustafa Şükrü (ORCID 0000-0002-1071-5291 & YÖK ID 122573), Tarım, Kayhan (ORCID 0000-0002-6071-1539 & YÖK ID 327605), Kiremit, Murat Can, Kılıç, Mert, Canda, Abdullah Erdem (ORCID 0000-0002-5196-653X & YÖK ID 116202), Kordan, Yakup (ORCID 0000-0002-9947-848X & YÖK ID 157552), Akyoldaş, Göktuğ, Solaroğlu, İhsan (ORCID 0000-0002-9472-1735 & YÖK ID 102059), Sasani, Mehdi, Gökler, Ozan (ORCID 0000-0003-1621-3687 & YÖK ID 311179), Ünsaler, Selin (ORCID 0000-0001-7108-9194 & YÖK ID 167909), Altuntaş, Muzaffer Ozan (ORCID 0000-0002-8747-7420 & YÖK ID 169795), Hafız, Ayşenur Meriç (ORCID 0000-0002-8003-7879 & YÖK ID 53676), Şimşek, Aykın, Deveci, Mehmet Ali (ORCID 0000-0002-3670-3985 & YÖK ID 206311), Korkmaz, Murat, Çakar, Nahit (ORCID 0000-0002-1302-9596 & YÖK ID 198906), Ergönül, Mehmet Önder (ORCID 0000-0003-1935-9235 & YÖK ID 110398), Cesur, Ezgi, Kırış, Talat, Giray, Burak, Koç University Hospital, School of Medicine
Rok vydání: 2021
Předmět:
Adult
Male
medicine.medical_specialty
Adolescent
Turkey
Disease
COVID-19
COVID-19-free surgical pathway
SARS-CoV2 infection
Cancer surgery
Cohort Studies
Young Adult
03 medical and health sciences
Postoperative Complications
0302 clinical medicine
COVID‐19
Neoplasms
medicine
Humans
Medicine
Oncology
Surgery
Young adult
Child
SARS‐CoV2 infection
Pandemics
Research Articles
Aged
Retrospective Studies
Aged
80 and over
SARS-CoV-2
business.industry
Mortality rate
COVID‐19‐free surgical pathway
Cancer
Retrospective cohort study
General Medicine
Perioperative
Middle Aged
medicine.disease
Elective Surgical Procedures
Child
Preschool
030220 oncology & carcinogenesis
Emergency medicine
Female
030211 gastroenterology & hepatology
cancer surgery
Elective Surgical Procedure
business
Research Article
Cohort study
Zdroj: Journal of Surgical Oncology
ISSN: 1096-9098
0022-4790
DOI: 10.1002/jso.26436
Popis: Background: we aimed to assess the feasibility and short-term clinical outcomes of surgical procedures for cancer at an institution using a coronavirus disease 2019 (COVID-19)-free surgical pathway during the peak phase of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Materials and methods: this was a single-center study, including cancer patients from all surgical departments, who underwent elective surgical procedures during the first peak phase between March 10 and June 30, 2020. The primary outcomes were the rate of postoperative SARS-CoV-2 infection and 30-day pulmonary or non-pulmonary related morbidity and mortality associated with SARS-CoV-2 disease. Results: four hundred and four cancer patients fulfilling inclusion criteria were analyzed. The rate of patients who underwent open and minimally invasive procedures was 61.9% and 38.1%, respectively. Only one (0.2%) patient died during the study period due to postoperative SARS-CoV2 infection because of acute respiratory distress syndrome. The overall non-SARS-CoV2 related 30-day morbidity and mortality rates were 19.3% and 1.7%, respectively; whereas the overall SARS-CoV2 related 30-day morbidity and mortality rates were 0.2% and 0.2%, respectively. Conclusions: under strict institutional policies and measures to establish a COVID-19-free surgical pathway, elective and emergency cancer operations can be performed with acceptable perioperative and postoperative morbidity and mortality.
NA
Databáze: OpenAIRE
Externí odkaz: